ScholarIQanswers from OpenAlex

Pathological evidence in support of total mesorectal excision in the management of rectal cancer

PaperCitations, authors & open-access status

Pathological evidence in support of total mesorectal excision in the management of rectal cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Pathological evidence in support of total mesorectal excision in the management of rectal cancer have?

ScholarIQcitation count

Pathological evidence in support of total mesorectal excision in the management of rectal cancer has 184 citations in the OpenAlex counts ScholarIQ stores.

When was Pathological evidence in support of total mesorectal excision in the management of rectal cancer published?

ScholarIQyear

Pathological evidence in support of total mesorectal excision in the management of rectal cancer has 1996 year in the ScholarIQ index.

What is the open-access status of Pathological evidence in support of total mesorectal excision in the management of rectal cancer?

ScholarIQoa status

Pathological evidence in support of total mesorectal excision in the management of rectal cancer has bronze oa status in the ScholarIQ index.

What is the DOI of Pathological evidence in support of total mesorectal excision in the management of rectal cancer?

ScholarIQdoi

The DOI for Pathological evidence in support of total mesorectal excision in the management of rectal cancer is on the source record.

What is the PMID of Pathological evidence in support of total mesorectal excision in the management of rectal cancer?

ScholarIQpmid

The PMID for Pathological evidence in support of total mesorectal excision in the management of rectal cancer is on the source record.

What is the OpenAlex record for Pathological evidence in support of total mesorectal excision in the management of rectal cancer?

ScholarIQopenalex

The OpenAlex for Pathological evidence in support of total mesorectal excision in the management of rectal cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial